PK

Pradip Kumar Majumder

Active Director Director DIN 02985222
DIN 02985222 First appointment Mar 2010 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Mar 2010
Shareholding value •••• Premium profile

About Pradip Kumar Majumder

Data last updated:

Pradip Kumar Majumder is a Director at Canfinis Therapeutics Private Limited (since 2025) and Director at Aryastha Life Sciences Private Limited (since 2023). The companies operate in Healthcare, Pharma and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹24.5 Lakh; the largest is Canfinis Therapeutics Private Limited at ₹23.7 Lakh (FY 2025). Earlier, Pradip Kumar Majumder was a Director at Shilps Sciences Private Limited (2022–2025) and Director at India Innovation Research Center (2011–2025) and 2 more.

DIN 02985222
Primary Designation Director
Industry Healthcare
First Appointment 31 Mar 2010
Oldest Company Age 16 yrs
Largest company Canfinis Therapeutics Private Limited · ₹23.7 Lakh (FY 2025)
Combined revenue ₹24.5 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Apr 20252021₹23.7 Lakh (FY 2025)Active
Director18 Jul 20232023₹84,462 (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shilps Sciences Private Limited U31401KA2013PTC072709
Director01 Nov 20222013₹26.6 Lakh (FY 2024)Active
India Innovation Research Center U93000KA2011NPL061831
Director26 Dec 20112011₹1.9 Lakh (FY 2025)Active
Director18 May 20162016₹6.66 Cr (FY 2022)Active
Mitra Biotech Private Limited U73100KA2009PTC051875
Director31 Mar 20102009₹1.36 Cr (FY 2016)Dissolved (Liquidated)

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Canfinis Therapeutics Private Limited
Mitra Biotech Private Limited
Aryastha Life Sciences Private Limited
Shilps Sciences Private Limited
Premium access

Shareholding and investment profile for Pradip Kumar Majumder

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pradip Kumar Majumder

Pradip Kumar Majumder currently holds 2 directorships: Canfinis Therapeutics Private Limited (Director, since 06 Apr 2025, revenue ₹23.7 Lakh (FY 2025)); Aryastha Life Sciences Private Limited (Director, since 18 Jul 2023, revenue ₹84,462 (FY 2024)).

Pradip Kumar Majumder was first appointed on 31 Mar 2010 as Director at Mitra Biotech Private Limited. The most recent appointment on record is 06 Apr 2025 at Canfinis Therapeutics Private Limited.

The 2 current companies of Pradip Kumar Majumder that report revenue have a combined latest revenue of ₹24.5 Lakh: Canfinis Therapeutics Private Limited ₹23.7 Lakh (FY 2025); Aryastha Life Sciences Private Limited ₹84,462 (FY 2024).

Pradip Kumar Majumder held 4 earlier board appointments: Shilps Sciences Private Limited (Director, 01 Nov 2022 to 29 Jul 2025); India Innovation Research Center (Director, 26 Dec 2011 to 28 Jul 2025); Farcast Biosciences India Private Limited (Director, 18 May 2016 to 29 May 2020); Mitra Biotech Private Limited (Director, from 31 Mar 2010).

The current boards of Pradip Kumar Majumder's companies include Amjad Hussain (Canfinis Therapeutics Private Limited), Chandra Chur Ghosh (Canfinis Therapeutics Private Limited), Mark Timothy Bilodeau (Aryastha Life Sciences Private Limited), Raghava Reddy Kethiri (Aryastha Life Sciences Private Limited), Rajasekar Narayanasamy (Aryastha Life Sciences Private Limited), Sivananda Reddy Mandra (Aryastha Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available